reimbursement

Enhancing patient access to advanced therapies 1:37
Enhancing patient access to advanced therapies
Delara Motlagh • 27 Jan 2022
A 2022 update of the Alliance for Regenerative Medicine 0:52
A 2022 update of the Alliance for Regenerative Medicine
Janet Lynch Lambert • 26 Jan 2022
Addressing issues in the clinical translation of cell & gene therapies 3:07
Addressing issues in the clinical translation of cell & gene therapies
Janet Lynch Lambert • 26 Jan 2022
Remaining barriers in commercializing advanced therapies 2:20
Remaining barriers in commercializing advanced therapies
Pascal Touchon • 22 Oct 2021
Remaining issues in developing advanced therapies 2:12
Remaining issues in developing advanced therapies
Christian Schneider • 29 Oct 2021
Addressing remaining barriers to the commercialization of ATMPs 2:07
Addressing remaining barriers to the commercialization of ATMPs
Matthew Durdy • 6 Oct 2021
Challenges facing the translation of cell & gene therapies 2:31
Challenges facing the translation of cell & gene therapies
Bruce Levine • 28 May 2021
Improving patient access to advanced therapies: are we ready for them? 3:41
Improving patient access to advanced therapies: are we ready for them?
Durhane Wong-Rieger • 6 Apr 2021
Improving patient access to cell & gene therapies 3:45
Improving patient access to cell & gene therapies
Miguel Forte • 26 May 2021
Improving patient access to advanced therapies 5:14
Improving patient access to advanced therapies
Ana Hidalgo-Simon • 7 Apr 2021
Accelerating commercialization in advanced therapies 3:08
Accelerating commercialization in advanced therapies
Pascal Touchon • 7 Apr 2021
The content of VJRegenMed is intended for healthcare professionals